- Home
- BEDU vs CTOR Comparison
BEDU vs CTOR Comparison
Compare BEDU & CTOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEDU
- CTOR
- Stock Information
- Founded
- BEDU 1994
- CTOR 2021
- Country
- BEDU United Kingdom
- CTOR United States
- Employees
- BEDU N/A
- CTOR N/A
- Industry
- BEDU Other Consumer Services
- CTOR
- Sector
- BEDU Real Estate
- CTOR
- Exchange
- BEDU Nasdaq
- CTOR NYSE
- Market Cap
- BEDU 54.0M
- CTOR 63.7M
- IPO Year
- BEDU 2017
- CTOR N/A
- Fundamental
- Price
- BEDU $1.85
- CTOR $1.97
- Analyst Decision
- BEDU
- CTOR Buy
- Analyst Count
- BEDU 0
- CTOR 2
- Target Price
- BEDU N/A
- CTOR $6.00
- AVG Volume (30 Days)
- BEDU 2.3K
- CTOR 3.1M
- Earning Date
- BEDU 08-01-2025
- CTOR 08-11-2025
- Dividend Yield
- BEDU N/A
- CTOR N/A
- EPS Growth
- BEDU N/A
- CTOR N/A
- EPS
- BEDU N/A
- CTOR N/A
- Revenue
- BEDU $224,321,752.00
- CTOR N/A
- Revenue This Year
- BEDU N/A
- CTOR N/A
- Revenue Next Year
- BEDU N/A
- CTOR N/A
- P/E Ratio
- BEDU N/A
- CTOR N/A
- Revenue Growth
- BEDU N/A
- CTOR N/A
- 52 Week Low
- BEDU $1.35
- CTOR $0.55
- 52 Week High
- BEDU $2.41
- CTOR $49.00
- Technical
- Relative Strength Index (RSI)
- BEDU 58.50
- CTOR N/A
- Support Level
- BEDU $1.76
- CTOR N/A
- Resistance Level
- BEDU $1.91
- CTOR N/A
- Average True Range (ATR)
- BEDU 0.05
- CTOR 0.00
- MACD
- BEDU 0.01
- CTOR 0.00
- Stochastic Oscillator
- BEDU 63.89
- CTOR 0.00
About BEDU Bright Scholar Education Holdings Limited each representing four
Bright Scholar Education Holdings Ltd operates as an education service provider. It is engaged in the provision of education services, including complementary education services, operation services for domestic schools, and education programs and services including independent schools and colleges in United Kingdom (the UK) and the United States (the U.S.) Kingdom. It nearly eight overseas school located in the United Kingdom and the United States. It has three reportable segments, including Overseas Schools, Complementary Education Services, and K-12 Operation Services. Key revenue is generated from Overseas Schools. From a geographical perspective: Key revenue is generated from China following UK, U.S., Canada and Singapore.
About CTOR CITIUS ONCOLOGY INC
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.